Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions

European Journal of Histochemistry

Volumn 51, Issue 3, 2007, Pages 193-198

  Ruggeri, R M ^a   Sciacchitano, S ^b,c   Trimarchi, F ^a   Barresi, G ^d   Trovato, Maria ^d  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

C met; Hashimoto's thyroiditis; Hepatocyte growth factor; Hyperplastic thyroid nodules

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GOITER; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PROTEIN EXPRESSION; STROMA CELL; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; NODULAR GOITER; PATHOLOGY; THYROID GLAND;

FEMALE; GOITER, NODULAR; HASHIMOTO DISEASE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; THYROID GLAND;

EID: 35748929095     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bidey SP, Hill DJ, Eggo MC. Growth factors and goitrogenesis. J Endocrinol 1999;160:321-32.
2. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8: 404-10.
3. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-4.
4. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996; 335:99-107.
5. Doniach D, Roitt MI. Human organ specific autoimmunity: personal memories. Autoimmunity 1988;1:11-3.
6. Gasbarri A, Sciacchitano S, Marasco A, Papotti M, Di Napoli A, Marzullo A, et al. Detection and molecular characterization of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. British J Cancer 2004; 91:1096-104.
7. Hayashi N, Tamaki N, Yamamoto K, Senda M, Yonekura Y, Misaki T, et al. Real-time ultrasonography of thyroid nodules. Acta Radiol Diagn (Stockh) 1986;27:403-8.
8. Jayaram G, Marwaha RK, Gupta RK, Sharma SK. Cytomorphologic aspects of thyroiditis. A study of 51 cases with functional, immunologic, and ultrasonographic data. Acta Cytol 1987;31: 687-93.
9. Li Volsi V. Lymphocytes in the thyroid. In: Li Volsi V, eds. Surgical Pathology of the Thyroid. W.B. Saunders Company, Philadelphia, 1990:pp. 68-97.
10. Li Volsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid 1994; 4:333-39.
11. Mineo R, Costantino A, Frasca F, Sciacca L, Russo S, Vigneri R, et al. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. Endocrinology. 2004;145:4355-65.
12. Mizukami Y, Michigishi T, Nonomura A, Nakamura S, Ishizaki T. Pathology of chronic thyroiditis: a new clinically relevant classification. Pathol Ann 1994; 29:135-58.
13. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-59.
14. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-43.
15. Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab 2006; 91:2414-23.
16. Ruco LP, Stoppacciano A, Ballarini F, Prat M, Scarpino S. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidenze for a pathogenetic role in tumorigenesis. J Pathol 2001;194: 4-8.
17. Ruggeri RM, Barresi G, Sciacchitano S, Trimarchi F, Benvenga S, Trovato M. Immunoexpression of the CD30 Ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases. Histol Histopathol 2006; 21:249-56.
18. Scarpino S, D'Alena FC, Di Napoli A, Ballarini F, Prat M, Ruco LP. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. J Pathol 2003;199:243-50.
19. Trovato M, Villari D, Bartolone L, Spinella S, Simone A, Violi MA, et al. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules. Thyroid 1998;8:125-31.
20. Trovato M, Fragetta F, Villari D, Batolo D, MacKey K, Trimarchi F, et al. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.J Clin Endocrinol Metab 1999;84:3235-40.
21. Trovato M, Grosso M, Vitarelli E, Ruggeri RM, Alesci S, Trimarchi F, et al. Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas. Histol Histopathol 2003;18:393-99.
22. Trovato M, Ulivieri A, Dominici R, Ruggeri RM, Vitarelli E, Benvenga S, et al. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions. Endocr Relat Cancer 2004;11:365-76.
23. Vesely D, Astl J, Lastuvka P, Matucha P, Sterzl I, Betka J. Serum levels of IGF-I, HGF, TGFbeta1, bFGF and VEGF in thyroid gland tumors. Physiol Res 2004; 53:83-9.
24. Weetman AP, Mc Gregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994; 15:788-830.